{
  "retracted": false,
  "timestamp": 1554076800000,
  "updates": [
    {
      "timestamp": 1574889888917,
      "identifier": {
        "doi": "10.1016/j.biopha.2019.108755"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.biopha.2018.11.065"
  },
  "journal": "Biomedicine & Pharmacotherapy",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC” [Biomed. Pharmacother. 110 (2019) 656–666]"
}
